GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IMBdx Inc (XKRX:461030) » Definitions » Beneish M-Score

IMBdx (XKRX:461030) Beneish M-Score


View and export this data going back to 2024. Start your Free Trial

What is IMBdx Beneish M-Score?

IMBdx does not have enough data to calculate Beneish M-Score.


IMBdx Beneish M-Score Historical Data

The historical data trend for IMBdx's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMBdx Beneish M-Score Chart

IMBdx Annual Data
Trend Dec21 Dec22 Dec23
Beneish M-Score
- - -

IMBdx Quarterly Data
Dec21 Dec22 Mar23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial - - - - -

Competitive Comparison of IMBdx's Beneish M-Score

For the Diagnostics & Research subindustry, IMBdx's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IMBdx's Beneish M-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IMBdx's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where IMBdx's Beneish M-Score falls into.


;
;

IMBdx Business Description

Traded in Other Exchanges
N/A
Address
131 Gasandigital 1-ro, 21st Floor BYC Highcity Building A, Geumcheon-gu, Seoul, KOR, 08506
IMBdx Inc detects and analyzes the genomic profile of tumor DNA with a single draw of blood. It provides personalized and optimized analysis information that can be utilized in therapy selection and monitoring. Its AlphaLiquid platform offers ctDNA-based precision diagnostics solutions across the full continuum of cancer care, from therapy selection (AlphaLiquid 100/HRR) to recurrence and minimal residual disease(MRD) monitoring (CancerDetect), and multi-cancer early detection (CancerFind). Its services are Clinical Service BioPharma, Research, and Healthcare Checkup.

IMBdx Headlines

No Headlines